Quantcast

Breast Cancer Drug a Big Step Forward

June 25, 2008

By Claire Harrison

Dr Seamus McAleer has been involved in trials of a new drug called Lapatinib at Belfast City Hospital which has offered women suffering a type of advanced breast cancer hope by slowing the disease.

Around 1,000 women are diagnosed with breast cancer in Northern Ireland every year, with a quarter suffering the aggressive, fast- growing ErbB2-positive kind of the disease.

For many women with this form of the disease who initially respond to treatment with Herceptin and chemotherapy, the cancer will start to grow again within a year of starting treatment.

Lapatinib is specifically targeted at patients facing this situation, a stage at which there are very few treatment options available.

Manufacturer GlaxoSmithKline said that Lapatinib, taken along with the standard chemo drug capecitabine, “has shown to delay the time its takes for cancer to worsen”.

(c) 2008 Belfast Telegraph. Provided by ProQuest Information and Learning. All rights Reserved.




comments powered by Disqus